Tanshinone I and Tanshinone IIA/B attenuate LPS-induced mastitis via regulating the NF- κB.

CONCLUSION: Tanshinone I and Tanshinone IIA/B have potentials in treating mastitis. The beneficial effects might be through regulating NF-κB activation. PMID: 33578236 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33578236?dopt=Abstract

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - February 9, 2021 Category: Drugs & Pharmacology Authors: Yang L, Zhou G, Liu J, Song J, Zhang Z, Huang Q, Wei F Tags: Biomed Pharmacother Source Type: research